Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for advanced AV block after heart valve surgery
IRCT20180430039488N1Phase 3Completed
- Sponsor
- Tehran Heart Center
- Start
- Mar 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexamethasone in atrioventricular block (2 arms), sponsored by Tehran Heart Center. Primary endpoints: Frequency of recovery of AV block 5 days after cardiac surgery and Time to recovery of AV block. Started Mar 2019; status: completed.
02
Drugs
dexamethasone
03
Conditions
atrioventricular block
Beyond the preview
Go deeper on IRCT20180430039488N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180430039488N1.